Woodard & Company Asset Management Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-75
| Closed | -$7K | – | 127 |
|
2022
Q1 | $7K | Hold |
75
| – | – | ﹤0.01% | 111 |
|
2021
Q4 | $8K | Hold |
75
| – | – | ﹤0.01% | 95 |
|
2021
Q3 | $9K | Hold |
75
| – | – | 0.01% | 98 |
|
2021
Q2 | $10K | Hold |
75
| – | – | 0.01% | 97 |
|
2021
Q1 | $10K | Hold |
75
| – | – | 0.01% | 106 |
|
2020
Q4 | $11K | Buy |
+75
| New | +$11K | 0.01% | 96 |
|